Close
ACHEMA MIDDLE EAST 2026

Jemperli From GSK Beats Keytruda In Lung Cancer Head-To-Head

The standard therapy for newly diagnosed metastatic non-small cell lung cancer is Keytruda by Merck. That is the standard that PD-1 latecomer GSK's Jemperli...

The Solution To Neurological Problems May Lie In Junk DNA

According to recent studies, there is a connection between non-coding DNA and some neurological diseases such as Alzheimer's and motor neurone disease. Researchers from the...

The FDA Increases Patient Input During Drug Development

The FDA started a programme ten years ago to increase the role of patients in educating sponsors and regulators on the most detrimental impacts...

DEKRA Is Chosen By MHRA To Accredit Medical Devices In UK

The three current UK-approved bodies have been joined by DEKRA Certification UK, according to the Medicines and Healthcare Products Regulatory Agency (MHRA), enhancing the...

A NIH Study Ties COVID Vaccine To Increased Menstrual Cycle

An extensive worldwide study supported by the National Institutes of Health found a modest increase in the length of a woman's menstrual cycle after...

Indian Biotech Needs Faster Regulatory Processes- Report

According to a report by the Indian industry group CII, there is a need to expedite regulatory processes and eliminate unnecessary stages to speed...

Roche Pays $70M To Close The Gap On Cancer Cell Treatments

A private biotechnology startup called Arsenal Biosciences will receive $70 million from Roche in exchange for access to technology that the two businesses believe...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...